ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 83 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $501,000 | +615.7% | 7,900 | +217.7% | 0.00% | – |
| Q3 2019 | $70,000 | +25.0% | 2,487 | +19.2% | 0.00% | – |
| Q2 2019 | $56,000 | +55.6% | 2,087 | +8.0% | 0.00% | – |
| Q1 2019 | $36,000 | +63.6% | 1,932 | +5.3% | 0.00% | – |
| Q4 2018 | $22,000 | +175.0% | 1,835 | +358.8% | 0.00% | – |
| Q3 2018 | $8,000 | +300.0% | 400 | +33.3% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 300 | -33.3% | 0.00% | – |
| Q3 2016 | $3,000 | +200.0% | 450 | +80.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |